Search results
Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Up 4.3%
ETF DAILY NEWS· 5 hours agoJazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) was up 4.3% during trading on Friday . Needham & Company LLC reissued a “buy” rating and issued a $222.00 price objective ...
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $21.00 at Barclays
ETF DAILY NEWS· 2 days agoTeva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price target upped by Barclays from $20.00 to $21.00 in a research note issued to investors on Wednesday ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 8 hours agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat ...
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Insider Weiss Amir sells 12,635 Shares – Knox Daily
Knox Daily· 4 days agoTeva- Pharmaceutical Industries Ltd. ADR’s recently made public that its Chief Accounting Officer Weiss Amir unloaded Company’s shares for reported $0.21 million on May 16 ...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks· 5 days agoTeva Pharmaceutical Industries Limited’s (TEVA Quick QuoteTEVA - Free Report) revenues have suffered...
Celebrity doctors promoted Covid vaccine without declaring payments
The Telegraph via Yahoo News· 19 hours agoThe pharmaceutical watchdog has been urged to investigate after a string of celebrity doctors took...
All You Need to Know About ASLAN Pharmaceuticals (ASLN) Rating Upgrade to Buy
Zacks via Yahoo Finance· 5 days agoASLAN Pharmaceuticals (ASLN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism...
It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 2 days agoWhile this analysis focuses on total compensation, it's worth acknowledging that the salary portion...
Justin Liby on Pharmaceutical Industry | JD Supra
JD Supra· 3 days agoJD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. This Privacy Policy describes how JD Supra ...
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its...
Simply Wall St. via Yahoo Finance· 22 hours agoRegeneron Pharmaceuticals' (NASDAQ:REGN) stock up by 4.9% over the past month. Since the market...